Publications by authors named "Jochen Lorch"

70Publications

Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19.

Oral Oncol 2021 01 6;112:105087. Epub 2020 Nov 6.

Dana-Farber Cancer Institute, Center for Head & Neck Oncology, Boston, MA; Department of Surgery, Division of Otolaryngology-Head & Neck Surgery, Brigham & Women's Hospital, Boston, MA.

View Article and Find Full Text PDF
January 2021

Efficacy of Selpercatinib in -Altered Thyroid Cancers.

N Engl J Med 2020 08;383(9):825-835

From Massachusetts General Hospital (L.J.W.) and Dana-Farber Cancer Institute (J. Lorch), Boston; Memorial Sloan Kettering Cancer Center, New York (E.S., A.D.); Royal North Shore Hospital, St. Leonards, NSW (B.R.), and Peter MacCallum Cancer Institute, Melbourne, VIC (B.S.) - both in Australia; University of California, San Francisco-Helen Diller Family Comprehensive Cancer Center, San Francisco (H.K.), David Geffen School of Medicine at UCLA, Los Angeles (J.W.G.), and Chao Family Comprehensive Cancer Center, University of California Irvine, Orange (V.W.Z.) - all in California; University of Michigan, Ann Arbor (F.W.), and START Midwest, Grand Rapids (N.L.) - both in Michigan; University of Pennsylvania, Philadelphia (M.B.); University of Chicago, Chicago (J.P.); Gustave Roussy, Villejuif (S.L.), Institut Bergonié, Bordeaux (Y.G.), Aix Marseille University, Centre National de la Recherche Scientifique, INSERM, Centre de Recherche en Cancérologie de Marseille, Assistance Publique-Hôpitaux de Marseille, Early Phase Cancer Trial Center CLIP2, Hospital La Timone, Marseille (F.B.), Centre Léon Bérard, Lyon (C.D.L.F.), and Hôpital Européen Georges-Pompidou, Faculté de Médecine Paris-Descartes, Paris (J.M.) - all in France; Mayo Clinic-Rochester, Rochester, MN (J.C.M.); Winship Cancer Institute of Emory University, Atlanta (T.K.O.); National Cancer Center Singapore, Singapore (D.S.W.T.); University of Bern, Bern, and Cantonal Hospital of Lucerne, Lucerne - both in Switzerland (O.G.); University of North Carolina-Chapel Hill, Chapel Hill (J.W.); University of Wisconsin-Carbone Cancer Center, Madison (M.E.B.); British Columbia Cancer Agency, Vancouver, Canada (J. Laskin); Oregon Health and Science University, Portland (M.H.T.); Universitätsklinikum Würzburg, Department of Internal Medicine I, Division of Endocrinology and Diabetology, Würzburg, Germany (M.K.); Sarah Cannon Research Institute-Tennessee Oncology, Nashville (T.M.B.); Johns Hopkins Kimmel Cancer Center, Washington, DC (B.L.); Fundación Jimenez Diaz, START-Madrid, Madrid (V.M.); Loxo Oncology, Stamford, CT (K.E., M.N., D.H., E.Y.Z., X.H., L.Y., J.K., S.M.R.); University of Texas M.D. Anderson Cancer Center, Houston (V.S., M.E.C.); and Ohio State University Comprehensive Cancer Center, Columbus (M.H.S.).

View Article and Find Full Text PDF
August 2020

Histological features of BRAF V600E-mutant anaplastic thyroid carcinoma.

Histopathology 2020 Aug 23;77(2):314-320. Epub 2020 Jul 23.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article and Find Full Text PDF
August 2020

Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma.

Oral Oncol 2020 07 11;106:104690. Epub 2020 Apr 11.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; BC Cancer, Vancouver Centre, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada.

View Article and Find Full Text PDF
July 2020

The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature.

Oncologist 2020 06 11;25(6):505-514. Epub 2020 Feb 11.

Department of Medical Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts, USA.

View Article and Find Full Text PDF
June 2020

A potential diagnostic pitfall for hobnail variant of papillary thyroid carcinoma.

Histopathology 2020 Apr 13;76(5):707-713. Epub 2020 Apr 13.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article and Find Full Text PDF
April 2020

Treatment of Aggressive Thyroid Cancer.

Surg Pathol Clin 2019 Dec;12(4):943-950

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, D2136, Boston, MA 02115, USA. Electronic address:

View Article and Find Full Text PDF
December 2019

Ketogenic diet combined with antioxidant N-acetylcysteine inhibits tumor growth in a mouse model of anaplastic thyroid cancer.

Surgery 2020 01 12;167(1):87-93. Epub 2019 Sep 12.

Department of Surgery, Brigham and Women's Hospital, Boston, MA. Electronic address:

View Article and Find Full Text PDF
January 2020

Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma.

Thyroid 2019 09;29(9):1255-1261

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article and Find Full Text PDF
September 2019

Clinicopathologic Features of Mismatch Repair-Deficient Anaplastic Thyroid Carcinomas.

Thyroid 2019 05 16;29(5):666-673. Epub 2019 Apr 16.

1 Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article and Find Full Text PDF
May 2019

Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinoma.

Oral Oncol 2018 10 17;85:29-34. Epub 2018 Aug 17.

Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA 703-389-1895, United States. Electronic address:

View Article and Find Full Text PDF
October 2018

Lenvatinib-Associated Cervical Artery Dissections in a Patient with Radioiodine-Refractory Metastatic Papillary Thyroid Carcinoma.

Front Med (Lausanne) 2017 23;4:220. Epub 2018 Feb 23.

Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.

View Article and Find Full Text PDF
February 2018

Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

Cancer Discov 2018 02 3;8(2):196-215. Epub 2017 Nov 3.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article and Find Full Text PDF
February 2018

A case of primary secretory carcinoma of the thyroid with high-grade features.

Histopathology 2017 10 13;71(4):665-669. Epub 2017 Jul 13.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article and Find Full Text PDF
October 2017

Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma.

Cancer 2017 Jul 21;123(14):2642-2650. Epub 2017 Feb 21.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article and Find Full Text PDF
July 2017

Successful Management of a Patient with Malignant Thyroid Teratoma.

Thyroid 2017 01 28;27(1):125-128. Epub 2016 Nov 28.

4 Department of Otolaryngology, Brigham and Women's Hospital , Boston, Massachusetts.

View Article and Find Full Text PDF
January 2017

Exceptional Responders Inspire Change: Lessons for Drug Development From the Bedside to the Bench and Back.

Oncologist 2015 Jul 3;20(7):699-701. Epub 2015 Jun 3.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA

View Article and Find Full Text PDF
July 2015

Genomic analysis of metastatic cutaneous squamous cell carcinoma.

Clin Cancer Res 2015 Mar 14;21(6):1447-56. Epub 2015 Jan 14.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts.

View Article and Find Full Text PDF
March 2015

Response and acquired resistance to everolimus in anaplastic thyroid cancer.

N Engl J Med 2014 Oct;371(15):1426-33

From the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School (N.W., E.M.V.A., N.G., R.I.H., D.J.K., P.A.J., L.A.G., J.H.L.), the Department of Medicine, Brigham and Women's Hospital and Harvard Medical School (N.W., E.M.V.A., Y.G., R.I.H., D.J.K., P.A.J., L.A.G., J.H.L.), the Departments of Pathology (J.A.B.) and Surgery (S.J.S., D.T.R.), Brigham and Women's Hospital, the Department of Medicine, Beth Israel Deaconess Medical Center (G.J.H.), and Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute (P.A.J.) - all in Boston; and Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard (N.W., E.M.V.A., A.A.-M., A.T.-W., M.R., G.G., D.J.K., S.L.C., D.M.S., L.A.G.), Whitehead Institute for Biomedical Research and the MIT Department of Biology (B.C.G., D.M.S.), and Howard Hughes Medical Institute, MIT (B.C.G., D.M.S.) - all in Cambridge, MA.

View Article and Find Full Text PDF
October 2014

Pilot study: Raman spectroscopy in differentiating premalignant and malignant oral lesions from normal mucosa and benign lesions in humans.

Head Neck 2015 Apr 3;37(4):511-7. Epub 2014 Apr 3.

Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts; Divisions of Oral Medicine, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.

View Article and Find Full Text PDF
April 2015

Induction chemotherapy for locoregionally advanced head and neck cancer: past, present, future?

Oncologist 2013 26;18(3):288-93. Epub 2013 Feb 26.

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

View Article and Find Full Text PDF
September 2013

Trastuzumab for the treatment of salivary duct carcinoma.

Oncologist 2013 21;18(3):294-300. Epub 2013 Feb 21.

Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article and Find Full Text PDF
September 2013

Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.

Lancet Oncol 2013 Mar 13;14(3):257-64. Epub 2013 Feb 13.

Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article and Find Full Text PDF
March 2013

Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trial.

Cancer 2012 Apr 25;118(7):1811-7. Epub 2011 Aug 25.

Experimental Therapeutics Program, University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland 21201, USA.

View Article and Find Full Text PDF
April 2012

Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy.

Int J Radiat Oncol Biol Phys 2011 Nov 29;81(4):e215-22. Epub 2011 Apr 29.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

View Article and Find Full Text PDF
November 2011

Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer.

Authors:
Jochen H Lorch

Cancer Manag Res 2009 Nov 3;1:151-4. Epub 2009 Nov 3.

Dana Farber Cancer Institute, Boston, MA, USA.

View Article and Find Full Text PDF
November 2009

Seeking alternative biological therapies: the future of targeted molecular treatment.

Oral Oncol 2009 Apr-May;45(4-5):447-53. Epub 2008 Nov 21.

Dana Farber Cancer Institute, 44 Binney Street, SW430, Boston, MA 02115, USA.

View Article and Find Full Text PDF
May 2010

Induction chemotherapy in locally advanced head and neck cancer: a new standard of care?

Hematol Oncol Clin North Am 2008 Dec;22(6):1155-63, viii

Dana Farber Cancer Institute, SW430, 44 Binney Street, Boston, MA 02115, USA.

View Article and Find Full Text PDF
December 2008

Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells.

J Biol Chem 2004 Aug 16;279(35):37191-200. Epub 2004 Jun 16.

Departments of Pathology and Dermatology, The Robert H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine, 303 East Chicago Avenue, Chicago, IL 60611, USA.

View Article and Find Full Text PDF
August 2004